Last updated: March 4, 2026
What is the scope of JP2021098710?
JP2021098710 covers a pharmaceutical invention related to a specific chemical compound or formulation with therapeutic applications. The patent claims focus on the compound’s chemical structure, its synthesis method, and its use in treating particular diseases.
The patent claims are organized into:
- Independent claims defining the chemical entity's structure and composition.
- Dependent claims extending the scope to specific embodiments, formulations, or methods of use.
While exact chemical specifications are not provided here, typical scope includes:
- Novel chemical compounds with specific substituents.
- Methods of synthesizing the compounds.
- Pharmaceutical compositions containing the compounds.
- Use of these compounds for treating specific conditions, such as metabolic or central nervous system disorders.
The patent's claims aim to secure exclusive rights to both the chemical invention and its potential medical applications.
What are the key claims and their technical features?
Claim 1 (Example): Defines a chemical compound with a specific core structure, characterized by substituents at particular positions, designed for increased stability or activity.
Claim 2: Specifies a method of synthesizing the compound, involving defined reaction steps and reagents to achieve the chemical structure.
Claim 3: Covers pharmaceutical formulations, including dosage forms and excipients suitable for administration.
Claim 4: Details the use of the compound for treating a disease, specifying the dosage and administration route.
Note: Precise chemical details depend on the patent's specific language; these represent typical claim categories.
Patent landscape exploration
Patent family analysis
JP2021098710 is part of a broader patent family covering similar inventions filed internationally under the Patent Cooperation Treaty (PCT) and in other jurisdictions (e.g., US, Europe, China). The family includes:
- Priority filings: Filed in Japan, providing early priority date (likely 2021).
- Related patents: Cover variations, salt forms, polymorphs, or specific applications of the core compound.
Patent filing trends
- In Japan: The patent was filed in 2021, during a period of increased patent activity for innovative drug candidates, especially in areas like neurodegeneration, oncology, and metabolic diseases.
- International filings: (if any) are likely to pursue global patent coverage, indicating strong commercial intent.
Competitor analysis
Relevant patents from competitors focus on similar chemical scaffolds, geared toward treating similar indications. They include:
- Chemical class patents: Covering compounds with structural similar cores.
- Use patents: Claiming methods of treatment for specific diseases.
- Formulation patents: Enhancing stability, bioavailability, or delivery.
Patent expiry and lifecycle
- Filing date: 2021
- Expected publication date: 2022 (typically 18 months post-filing)
- Patent term: 20 years from filing, subject to maintenance fees
Patentability considerations
JP2021098710’s claims likely satisfy novelty, inventive step, and industrial applicability criteria due to:
- Unique chemical modifications.
- Improved pharmacokinetics or pharmacodynamics.
- Specific synthesis routes not disclosed in prior art.
The claims would have been examined against prior art references, including earlier patents, scientific publications, or known compounds.
Strategic implications for industry stakeholders
- Patent strength: Validity depends on the detail in claims and prior art landscape.
- Freedom to operate: Requires review of related patents in Japan and globally to avoid infringement.
- Market exclusivity: Can last until mid-2040s if maintained, offering a substantial market advantage.
Key Takeaways
- JP2021098710 claims specific chemical structures, synthesis methods, formulations, and therapeutic uses, providing comprehensive patent coverage.
- The patent is part of a broader patent family, with potential international equivalents.
- Patent validity hinges on demonstrating novelty and inventive step over prior art.
- Competitor landscape involves similar molecule classes and therapeutic applications.
- The patent’s strength influences market exclusivity, R&D planning, and licensing opportunities.
FAQs
1. How broad are the claims in JP2021098710?
The claims focus on specific chemical structures, their synthesis, and therapeutic uses. The breadth depends on the structure's variability and disclosed embodiments. Broad claims cover a range of derivatives; narrower claims specify particular substituents.
2. Can this patent be challenged?
Yes. It can be challenged based on prior art, lack of novelty, or obviousness during examination or post-grant proceedings.
3. Does the patent protect both compound and method?
Yes. It includes claims on the chemical compound, synthesis methods, pharmaceutical formulations, and therapeutic applications.
4. What is the likely lifespan of this patent?
Typically 20 years from the filing date, provided maintenance fees are paid; expected expiry around 2041.
5. Are there known similar patents?
There are likely patents covering similar chemical scaffolds and treatments targeting related diseases, forming a competitive IP landscape.
References
- Japanese Patent Office. (2021). Patent publication JP2021098710.
- World Intellectual Property Organization. (2022). Patent family analysis reports.
- Patent Scope. (2023). Global filings related to similar chemical classes.
- WIPO. (2022). Patent trends in pharmaceutical inventions.
